{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:15:08Z","timestamp":1791832508918,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jamda.2025.105690","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T11:09:59Z","timestamp":1749294599000},"page":"105690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antithrombotic Therapy and Mortality Risk in Older Adults with Hip Fractures"],"prefix":"10.1016","volume":"26","author":[{"given":"Karin","family":"Vleeshouwers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke J.C.","family":"Bastings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"van den Boogaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn","family":"Poeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"van Es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nordin M.J.","family":"Hanssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffie","family":"Brouns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Magdelijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3062-2612","authenticated-orcid":false,"given":"Bart","family":"Spaetgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2025.105690_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s41999-018-0124-5","article-title":"Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis","volume":"10","author":"Palmer","year":"2019","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/j.jamda.2025.105690_bib2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jcin.2021.01.040","article-title":"Antithrombotic management of elderly patients with coronary artery disease","volume":"14","author":"Capranzano","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jamda.2025.105690_bib3","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/jgs.16549","article-title":"DOACs versus VKAs in older adults treated for acute venous thromboembolism: systematic review and meta-analysis","volume":"68","author":"Chaudhary","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2025.105690_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1182\/bloodadvances.2022007263","article-title":"Incidence and clinical impact of bleeding events in older patients with acute venous thromboembolism","volume":"7","author":"Ferrazzini","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jamda.2025.105690_bib5","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.7326\/M21-1094","article-title":"Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"174","author":"Khan","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2025.105690_bib6","first-page":"103","article-title":"Antiplatelet therapy in very elderly and comorbid patients with acute coronary syndromes","volume":"16","author":"De Rosa","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/j.jamda.2025.105690_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40266-024-01138-5","article-title":"Direct oral anticoagulants in older and frail patients with atrial fibrillation: a decade of experience","volume":"41","author":"Spruit","year":"2024","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2025.105690_bib8","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.3390\/jcm12185955","article-title":"Management of patients treated with direct oral anticoagulants in clinical practice and challenging scenarios","volume":"12","author":"Luc\u00e0","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jamda.2025.105690_bib9","first-page":"279","article-title":"Safety of switching from a vitamin K antagonist to a non-vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial","volume":"149","author":"Joosten","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jamda.2025.105690_bib10","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1111\/jgs.18894","article-title":"The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: an exploratory study","volume":"72","author":"de Jong","year":"2024","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2025.105690_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.105280","article-title":"Intra-individual variability of direct oral anticoagulant levels in frail older patients upon, during, and after acute hospitalization: the DOAC-FRAIL study","volume":"25","author":"de Jong","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.105690_bib12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jamda.2025.105690_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102144","article-title":"Health-related quality of life after first venous thromboembolism in individuals aged 70 years and older","volume":"7","author":"Wang","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jamda.2025.105690_bib14","first-page":"490","article-title":"The perioperative management of antiplatelet and anticoagulant drugs in hip fractures: do the surgery as early as possible","volume":"10","author":"Ghasemi","year":"2022","journal-title":"Arch Bone Jt Surg"},{"key":"10.1016\/j.jamda.2025.105690_bib15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/anae.16226","article-title":"Principles for management of hip fracture for older adults taking direct oral anticoagulants: an international consensus statement","volume":"79","author":"Mitchell","year":"2024","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jamda.2025.105690_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000521288","article-title":"Charlson comorbidity index: a critical review of clinimetric properties","volume":"91","author":"Charlson","year":"2022","journal-title":"Psychother Psychosom"},{"key":"10.1016\/j.jamda.2025.105690_bib17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged: the index of ADL: a standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2025.105690_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.injury.2009.01.010","article-title":"Timing of surgery for hip fractures: a systematic review of 52 published studies involving 291,413 patients","volume":"40","author":"Khan","year":"2009","journal-title":"Injury"},{"key":"10.1016\/j.jamda.2025.105690_bib19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s00590-018-2205-z","article-title":"Effect of blood transfusion on survival after hip fracture surgery","volume":"28","author":"Smeets","year":"2018","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"10.1016\/j.jamda.2025.105690_bib20","article-title":"Blood transfusions and hip fracture mortality - a retrospective cohort study","volume":"21","author":"Greenhalgh","year":"2021","journal-title":"J Clin Orthop Trauma"},{"key":"10.1016\/j.jamda.2025.105690_bib21","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.7326\/M20-7141","article-title":"Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: a cohort study","volume":"174","author":"Kim","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2025.105690_bib22","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jamda.2023.05.010","article-title":"Efficacy and safety of oral anticoagulants in older adult patients with atrial fibrillation: pairwise and network meta-analyses","volume":"24","author":"Wang","year":"2023","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.105690_bib23","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/jgs.15956","article-title":"Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients","volume":"67","author":"Deitelzweig","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2025.105690_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2024.105294","article-title":"Comparative effectiveness and safety of direct oral anticoagulants vs warfarin among nursing home residents with atrial fibrillation: a retrospective cohort study","volume":"25","author":"Mehta","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2025.105690_bib25","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1111\/jth.14977","article-title":"Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: a systematic review and meta-analysis","volume":"18","author":"Xu","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jamda.2025.105690_bib26","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1007\/s00068-022-01937-8","article-title":"Synthesis of the evidence on the impact of pre-operative direct oral anticoagulants on patient health outcomes after hip fracture surgery: rapid systematic review","volume":"48","author":"Mitchell","year":"2022","journal-title":"Eur J Trauma Emerg Surg"},{"key":"10.1016\/j.jamda.2025.105690_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.thromres.2020.03.002","article-title":"Preoperative direct oral anticoagulants treatment and all-cause mortality in elderly patients with hip fracture: a retrospective cohort study","volume":"189","author":"Saliba","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jamda.2025.105690_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1302\/0301-620X.103B2.BJJ-2020-0583.R2","article-title":"Effect of oral anticoagulant use on surgical delay and mortality in hip fracture","volume":"103-B","author":"You","year":"2021","journal-title":"Bone Joint J"},{"key":"10.1016\/j.jamda.2025.105690_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.thromres.2018.04.022","article-title":"Morbidity and mortality after fragility hip fracture surgery in patients receiving vitamin K antagonists and direct oral anticoagulants","volume":"166","author":"Frenkel Rutenberg","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jamda.2025.105690_bib30","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/BOT.0000000000001329","article-title":"Impact of direct oral anticoagulants in patients with hip fractures","volume":"33","author":"Bruckbauer","year":"2019","journal-title":"J Orthop Trauma"},{"key":"10.1016\/j.jamda.2025.105690_bib31","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.injury.2020.12.036","article-title":"Pre-injury use of antiplatelet and anticoagulations therapy are associated with increased mortality in a cohort of 1038 hip fracture patients","volume":"52","author":"Mahmood","year":"2021","journal-title":"Injury"},{"key":"10.1016\/j.jamda.2025.105690_bib32","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1016\/S2352-3026(24)00281-3","article-title":"Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants","volume":"11","author":"Ageno","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jamda.2025.105690_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110084","article-title":"Associations between presence of diabetes, mortality and fracture type in individuals with a hip fracture","volume":"192","author":"Spaetgens","year":"2022","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861025002075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861025002075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T07:36:40Z","timestamp":1778485000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861025002075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1525861025002075"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2025.105690","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy and Mortality Risk in Older Adults with Hip Fractures","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2025.105690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"105690"}}